BioSavita
Plymouth · Founded 1994
About BioSavita
BioSavita's high throughput synthetic DNA technologies and yeast strains enable the rapid manufacture of fully functional antibodies, single domain antibodies, antibody-drug conjugates and fusion proteins. They are focused on developing novel biological drugs and vaccines in partnership with biopharmaceutical companies and government agencies.
Company Facts
- Founded: 1994
- Legal name: BioSavita, Inc
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.0M
- Last round: Equity Crowdfunding (Oct 2014)
- Website: biosavita.com
- Phone: +1 (205) 447-1180
Canonical: https://fsome.com/organization/biosavita-8411601 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.